Hospital Infantil Universitario Niño Jesús

Madrid 65 28009

5 studies enrolling now · 20 studies all time

What they study most

Acute Myeloid Leukemia, Adolescent, Allergy, Atopic Dermatitis, Child, Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, Eczema, Fanconi Anemia, Genetic Obesity, Leukocyte Adhesion Deficiency, Low-grade Glioma, Neoplasms

Studies at this site

• A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer — Recruiting now
• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) — Recruiting now
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — Recruiting now
• Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) — Recruiting now
• Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia — Recruiting now
• Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow — Running, not enrolling
• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) — Running, not enrolling
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency — Paused
• Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102 — Enrolling by invitation
• Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures — Running, not enrolling
• Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I) — Running, not enrolling
• Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy — Stopped early
• Gene Therapy for Pyruvate Kinase Deficiency (PKD) — Completed
• Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy — Completed
• Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder — Running, not enrolling
• Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity — Completed
• A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) — Completed